Table 1.
Drug Class | CPE Score | ||
---|---|---|---|
1 | 0.5 | 0 | |
Nucleoside Reverse Transcriptase Inhibitor (NRTI) | Abacavir | Emtricitabine | Adefovir |
Zidovudine | Lamivudine | Zalcitabine | |
Stavudine | Didanosine | ||
Tenofovir | |||
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) | Delavirdine | Efavirenz | |
Nevirapine | |||
Protease Inhibitor (PI)* | Amprenavir-r | Amprenavir | Nelfinavir |
Darunavir | Atazanavir | Ritonavir | |
Fosamprenavir-r | Atazanavir-r | Saquinavir | |
Lopinavir-r | Fosamprenavir | Saquinavir-r | |
Indinavir-r | Indinavir | Tipranavir-r | |
Integrase Inhibitors | Elvitegravir | ||
Raltegravir | |||
Entry Inhibitors | Vicriviroc | Enfuvirtide | |
Maraviroc | T-1249 |
Antiretroviral Central Nervous System (ARV CNS); CNS penetration effectiveness (CPE); Amprenavir-r: Ritonavir boosted Amprenavir; Fosamprenavir-r: Ritonavir boosted Fosamprenavir; Lopinavir-r: Ritonavir boosted Lopinavir; Indinavir-r: Ritonavir boosted Indinavir; Atazanavir-r: Ritonavir boosted Atazanavir; Saquinavir-r: Ritonavir boosted Saquinavir; Tipranavir-r: Ritonavir boosted Tipranavir